Sign in
Active, not recruitingNo phase

The Role of Early Nursing Intervention in the High-risk Population of Gestational Diabetes

Key facts

Who runs it
Yan Lu
Where
China1 site in 1 countryChoose a country to see its sites
Trial code
Status
Active, not recruiting
People taking part
200 people, planned
Started
1 Jan 2025
Ended
30 Sept 2025
Type of study
Interventional, 2 groups
Treatments tested
  • Control group:The interactive management nursing model on the wechat platform
  • Intervention group:Family-centered early care intervention
Record updated
30 May 2025

Who can take part

Sex
Women only
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 22 criteriaShow less

Who can take part

  • Gestational age <10 weeks Singleton pregnancy confirmed by first-trimester ultrasound
  • Primary caregiver availability: At least one primary caregiver (spouse or parent) who:
  • Demonstrates adequate verbal communication and literacy skills (assessed by standardized evaluation)
  • Voluntarily participates in the study with signed informed consent; Metabolic risk factors meeting ≥1 criterion:
  • Pre-pregnancy BMI >24 kg/m²
  • Maternal age ≥35 years at conception
  • Documented history of polycystic ovary syndrome (PCOS)
  • Fasting blood glucose (FBG) ≥5.1 mmol/L in early pregnancy
  • Parental history of diabetes mellitus (either parent)
  • Previous gestational diabetes mellitus (GDM)
  • History of macrosomia (birth weight ≥4000g)
  • Adverse obstetric history including:; Preterm delivery (<37 weeks) Stillbirth or fetal demise Congenital malformations Neonatal death or unexplained neonatal death

Who cannot take part

  • Systemic corticosteroids (e.g., cortisone, prednisone); Activity-limiting comorbidities:
  • Pre-existing medical conditions:
  • Chronic hypertension (diagnosed pre-pregnancy)
  • Renal disorders (e.g., chronic kidney disease stage ≥3)
  • Cardiovascular diseases (e.g., coronary artery disease, heart failure); Prohibited medication use during pregnancy including:
  • Severe medical complications contraindicating physical activity (e.g., unstable angina, advanced respiratory failure)
  • Indomethacin
  • Phentolamine
  • Diuretics (e.g., furosemide, hydrochlorothiazide)
  • Phenytoin

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

Pregnant women who established prenatal examination cards in the prenatal outpatient department of our hospital from January 2025 to September 2025 were selected. According to the inclusion criteria, 200 high-risk pregnant women with gestational diabetes mellitus (GDM) were selected. 100 people in the control group received conventional nursing intervention measures, and 100 people in the intervention group adopted the family-centered wechat platform interactive management nursing model. The observation period was from the start of prenatal examination to follow-up until delivery. The blood glucose conditions, glycated hemoglobin (HbA1c) levels, incidence of GDM, and weight gain during pregnancy of the two groups of pregnant women were observed. The pregnancy outcomes included: Gestational age at delivery, gestational complications (gestational hypertension, diabetic ketosis, preterm birth, post-term pregnancy, urogenital tract infection), polyhydramnios, mode of delivery (induced labor, shoulder dystocia, cesarean section), premature rupture of membranes, postpartum complications (postpartum hemorrhage, puerperal infection), etc. Perinatal outcomes: including fetal growth restriction, macrosomia, preterm birth, stillbirth, fetal malformations, fetal distress, neonatal respiratory distress syndrome, neonatal hypoglycemia, etc. We applied FCC to pregnant women at high risk of gestational diabetes mellitus (GDM) and advanced the intervention window to the beginning of prenatal examination (8-10 weeks of pregnancy). This may be able to improve weight gain and blood glucose levels during pregnancy in high-risk pregnant women, reduce the incidence of GDM, improve the final maternal and infant outcomes, and provide a certain theoretical basis for prenatal nursing intervention in pregnant women at high risk of GDM in the future.

The 2 groups in the trial

  • Control groupTreatment being tested

    Treatment: Control group:The interactive management nursing model on the wechat platform

  • Intervention groupTreatment being tested

    Treatment: Intervention group:Family-centered early care intervention

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Research on the Preventive Effect of Family-centered Early Nursing Intervention on High-risk Population of Gestational Diabetes Mellitus
Record updated
30 May 2025